Stephan Goldenbaum has worked in biotech since 2003. Until 2017, he was head of sales in Europe, Africa and the Middle East working for QIAGEN, a leading global biotech company. From 2018 until joining Solis BioDyne, Goldenbaum worked on developing sales channels in the large Germany-based biotech company Eppendorf Group. Goldenbaum holds Master’s degrees in biology and business integration.
According to Stephan Goldenbaum, he considers his task to be the improvement of Solis BioDyne’s product development and sales, growing the company’s export volumes and expanding its network of partnerships. “We operate in the market of reagents, where export volumes are measured in millilitres. This means even more work needs to be done in research and development, that drives export. We want to work even more closely with research institutions, primarily the University of Tartu with whom we already have close relations. Solis BioDyne wants to continue to be one of the most attractive employers in Estonia for students and scientists of life-sciences. For example, we are very interested in recruiting people trained in biotechnology, chemistry, gene technology and bioanalytics,” says Goldenbaum.
Solis BioDyne is also preparing to build a larger and more modern new office and production building on Palsa Street in Tartu. “We are starting to outgrow our current premises in Tartu Science Park because our staff and production volumes have multiplied over the past couple of years. We hope to move into the new building equipped with a state-of-the-art biotech research and development unit in a year’s time,” explains Goldenbaum.
Salim Essakali, who also has long-term experience from the biotechnology company QIAGEN and the manufacturer of medical devices Boston Scientific, will also start working as the Head of Global Sales and Marketing of Solis BioDyne on September 1. 2021.
He has conducted his Master of Science in Molecular Pathology, holds an MBA in Corporate Strategy, and has extensive management experience developing, commercializing, and life-cycle-managing in BioTech and MedTech field.
OÜ Solis BioDyne operating in Tartu Science Park is one of Estonia’s leading biotech companies developing and producing reagents. DNA polymerases, PCR Master Mixes, qPCR Mixes and reverse transcription reagents are highly valued across the globe. Majority of its exports end up in Europe and the United States of America. Solis BioDyne uses unique genetic modification within all products to make them stable at room temperature for 30 days, to provide more sustainable and cost-effective solutions. The company was established in 1995 and now employs over 60 people.
Further information:
Sigrid HänniMarketing and Communication ManagerSOLIS BIODYNE OÜA: Teaduspargi 9, 50411 Tartu, EstoniaT: +372 5682 5751E: sigrid.hanni@solisbiodyne.comW: www.solisbiodyne.com
Have you ever used chat on our website to talk about our products or PCR or whatever came to your mind? Have you ever asked for advice from our customer support? If you have, the chances are you were talking to Birgit. She is the little miracle behind your perfectly functioning experiment. Now you have the opportunity to get to know her a little better.
Like with people, some products have better chemistry with each other than others. To make your life easier, we have many products in our portfolio that you can combine for your whole experiment setup. Here we have a short list of what is most compatible with what and how our partners have found a use for them.
When ideas and goals bring people together forming a community with a collective identity, inspiring individuals to take action and achieve great things, the power of those beliefs that unite them can be the force for real change in the world. In Solis BioDyne the curiosity and passion for exploring science and the responsibility with our environment is inspired by nature as the ultimate innovator, this is what identifies us.
This year seemed to just fly by because there was just so much happening all the time. It doesn’t feel that long ago when we did the recap for the year's first half. Now it’s time to focus on the second half of the year and all the wonder and joy we got to experience. As it is wintertime, feel free to grab a warm beverage and some gingerbread while you read.
